SCIESCOPUS
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
SAGE, United Kingdom
JOURNAL OF ONCOLOGY PHARMACY PRACTICE is an academic journal published by SAGE (United Kingdom). Identifiers: ISSN 1078-1552, eISSN 1477-092X. Indexed in SCIE, SCOPUS. Metrics: CiteScore 2.7, SJR 0.424, SNIP 0.56. Subject areas: ONCOLOGY, PHARMACOLOGY & PHARMACY. tlooto lists 3,476 papers from this journal.
CiteScore
2.70
Scopus citation metric
SJR
0.424
SCImago rank
SNIP
0.56
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1078-1552
- eISSN
- 1477-092X
- Abbreviation
- -
- Publisher
- SAGE
- Country
- United Kingdom
Web of Science categories
SCIEONCOLOGY, PHARMACOLOGY & PHARMACY
Scopus ASJC categories
2730 Oncology2736 Pharmacology (medical)
Keywords
Oncology | Pharmacology & Pharmacy
Papers in this journal
Recent papers
- Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing.
2026
- Identifying the needs of community pharmacists to ensure continuity of pharmaceutical care for oncology patients: A qualitative study.
2026
- Real-world evaluation of large language models in detecting drug-related problems: A clinical pharmacist-AI concordance study in hematology care.
2026
- Clinical utility of immature granulocyte monitoring for optimizing g-CSF use during chemotherapy-induced neutropenia.
2026
- Impact of the oncoral patient education follow-up program on the acquisition of knowledge about oral anticancer drugs.
2026
Most cited papers
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
2019 · 309 citations
- Management of hand-foot syndrome induced by capecitabine
2006 · 170 citations
- Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device
2011 · 158 citations
- Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice
2011 · 155 citations
- Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance
2020 · 150 citations